A third retraction stemming from Cardiff investigations

We’ve been reporting on retractions of research published by Cardiff University scientists following an investigation into their work. On Monday, we noted a new retraction of work by the group in Cancer Research, which we thought was the second retraction following one in the Journal of Immunology in 2011. But it turns out there was … Continue reading A third retraction stemming from Cardiff investigations

PubMed now allows comments on abstracts — but only by a select few

PubMed today launches a pilot version of PubMed Commons, a system that enables researchers to share their opinions about scientific publications. Researchers can comment on any publication indexed by PubMed, and read the comments of others. In general, we’re big fans of post-publication peer review, as Retraction Watch readers know. Once it’s out of its … Continue reading PubMed now allows comments on abstracts — but only by a select few

Researcher who threatened Retraction Watch with lawsuit corrects funding source for several papers

Ariel Fernandez, an Argentine chemist (who claims to hold the fastest-awarded PhD from Yale) and the subject of institutional investigations at multiple universities, has corrected several papers recently. What makes the moves particularly unusual — and interesting — is the stated reason for the amendments: disclaiming any funding from the National Institutes of Health for … Continue reading Researcher who threatened Retraction Watch with lawsuit corrects funding source for several papers

A Cancer Cell mega-correction for highly cited researcher who retracted paper earlier this year

MIT’s Robert Weinberg, a leading cancer researcher who retracted a Cancer Cell paper earlier this year for “inappropriate presentation” of figures, has corrected a different paper in the same journal. Here’s the correction for “Species- and Cell Type-Specific Requirements for Cellular Transformation:” We were apprised recently of errors made in the assembly of Figures 2B, … Continue reading A Cancer Cell mega-correction for highly cited researcher who retracted paper earlier this year

Cell attributes image problems in cloning paper to “minor” errors; sees no impact on conclusions

Yesterday we reported that Cell was looking into problematic images in a recent paper on human embryonic stem cell cloning. We’ve now heard from the journal about the nature of the inquiry. Mary Beth O’Leary, a spokeswoman for Cell Press — an Elsevier title — tells us that: Based on our own initial in-house assessment … Continue reading Cell attributes image problems in cloning paper to “minor” errors; sees no impact on conclusions

Cell reviewing allegations of image reuse in human embryonic stem cell cloning paper

Cell is looking into whether the authors of a widely hailed study published last week claiming to have turned human skin cells into embryonic stem cells manipulated images inappropriately, Retraction Watch has learned. The potential image problems came to light on PubPeer, a site designed to allow for post-publication peer review. A commenter, identified as … Continue reading Cell reviewing allegations of image reuse in human embryonic stem cell cloning paper